Anúncio
Anúncio

EVH

EVH logo

Evolent Health, Inc Class A Common Stock

4.14
USD
Patrocinado
+0.13
+3.11%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

4.14

0.00
0.00%

Relatórios de Lucros EVH

Rácio de surpresa positiva

EVH separação 30 de 40 últimas estimativas.

75%

Próximo Relatório

Data do Próximo Relatório
18 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$474.38M
/
$0.05
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-1.08%
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-26.63%
/
-350.00%

Evolent Health, Inc Class A Common Stock earnings per share and revenue

On 06 de nov. de 2025, EVH reported earnings of 0.05 USD per share (EPS) for Q3 25, missing the estimate of 0.10 USD, resulting in a -52.61% surprise. Revenue reached 479.53 milhão, compared to an expected 472.17 milhão, with a 1.56% difference. The market reacted with a -17.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of 0.05 USD, with revenue projected to reach 474.38 milhão USD, implying an aumentar of 0.00% EPS, and diminuir of -1.08% in Revenue from the last quarter.
FAQ
For Q3 2025, Evolent Health, Inc Class A Common Stock reported EPS of $0.05, missing estimates by -52.61%, and revenue of $479.53M, 1.56% above expectations.
The stock price moved down -17.33%, changed from $6.00 before the earnings release to $4.96 the day after.
The next earning report is scheduled for 18 de fev. de 2026.
Based on 16 analistas, Evolent Health, Inc Class A Common Stock is expected to report EPS of $0.05 and revenue of $474.38M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio